Optimizerx CorporationOTCBB:OPRXOPTIMIZERx Corporation400 Water Street, Suite 200Rochester, MI 48307Phone: 248.651.6568Fax...
SAFE HARBOR :This presentation contains forward-looking statements within the definition ofSection 27A of the Securities A...
Whats Changing in the Drug Industry?“Pharma Reps & Samples Decline In Size, Effectiveness, and ROI”                 Sales ...
Patient Cost’s is also impacting PharmaceuticalPromotion as the rise in co-pay costs is now a barrier                     ...
Key Trends—Trial Vouchers & Coupons Drive Adherence!  Co-Pay Cards And Coupons: Letting The Facts Get In The Way   Impact ...
Trial Vouchers & Coupons Are Now Replacing SamplesIndustry report conservatively made the following assumptions: • Nearly ...
Market Size— Physicians Practice Flow is now Electronic!eprescribing to grow by 600% in five years.?       Did You Know…  ...
SampleMD is partnering with the largest‘ePrescribing’ and electronic healthcare record (EHR)software platforms to reach mo...
SampleMD: How it worksSampleMD is a software application that replaces drug samples by allowingdoctors to automatically ad...
SampleMD provides Clear Solutions:SampleMD enables branded drug manufacturersaccess to providers with out sales personnel,...
SampleMD™ Promotional TechnologyEach Platform Offers A Cost-Effective SolutionOptimizeRx website—industry standard,rules-b...
SampleMD™ Promotional TechnologyPromotion to Doctors at Most Critical Time: Point of Prescribe!                           ...
Our Key Health Systems & EHR/ ePrescribe Platform Partners
Key Health Pharmaceutical & Health Care Clients“Building the premier digital path to deliver direct           support from...
SampleMD Revenue Metrics: “Highly Leveraged”                                        Set Up Fee:                           ...
SampleMD Actual Usage Metrics July 2011-July2012
OPRX FISCAL PERFORMANCE Q3 2011 v. Q3 2012Fiscal period   Revenue for period   9 Mos      Q3 loss        9 mos total      ...
Thank you for your interest in OPRX Key Stock Data:              Equivalents:                  Financial Summary Recent Pr...
MicroCapClub Invitational: OptimizeRx (OPRX)
Upcoming SlideShare
Loading in …5
×

MicroCapClub Invitational: OptimizeRx (OPRX)

1,053 views

Published on

Welcome to the first ever MicroCapClub Invitational where our membership is showcasing several companies we are discussing in our members forum. The government is mandating the switch to electronic health records (EHR) over the next few years, which is also propelling physician’s use of e-prescriptions. E-prescriptions are expected to grow from 570 million in 2011 to 2 billion by 2016. So who is the microcap benefactor of this trend? Enter, OptimizeRx (OPRX) and their SampleMD e- coupon software that is currently embedded in over 300 EHR’s/e-prescribe software providers including the largest ones such as Allscripts (MDRX), NewCrop, and Dr. First. OptimizeRX gets paid $4-5 each e-coupon distribution. The operating leverage in the business is quite extraordinary as more and more pharmaceutical companies partner with SampleMD for e-coupons. Listen to Chairman and Founder Dave Harrell and CEO David Lester as they tell the story.

Published in: Economy & Finance
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,053
On SlideShare
0
From Embeds
0
Number of Embeds
562
Actions
Shares
0
Downloads
7
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

MicroCapClub Invitational: OptimizeRx (OPRX)

  1. 1. Optimizerx CorporationOTCBB:OPRXOPTIMIZERx Corporation400 Water Street, Suite 200Rochester, MI 48307Phone: 248.651.6568Fax: 248.453.5529http://www.optimizerxcorp.com/
  2. 2. SAFE HARBOR :This presentation contains forward-looking statements within the definition ofSection 27A of the Securities Act of 1933, as amended and such section 21E of theSecurities Act of 1934, amended. These forward-looking statements should not beused to make an investment decision. The words estimate, possible and seeking and similar expressions identifyforward-looking statements, which speak only as to the date the statement wasmade. The company undertakes no obligation to publicly update or revise anyforward-looking statements, whether because of new information, future events,or otherwise.Forward-looking statements are inherently subject to risks and uncertainties, someof which cannot be predicted, or quantified. Future events and actual results coulddiffer materially from those set forth in, contemplated by, or underlying theforward-looking statements. The risks and uncertainties to which forward-lookingstatements are subject include, but are not limited to, the effect of governmentregulation, competition and other material risks.
  3. 3. Whats Changing in the Drug Industry?“Pharma Reps & Samples Decline In Size, Effectiveness, and ROI” Sales Rep Attrition Visits With Samples (Millions)105,000 120 11090,000 100 9075,000 80 7060,000 60 2003 2007 2009 2012 2007 2008 2009 2010 2011 ? Did You Know… Source: 2. Cegedim Strategic Data According to the spring 2011 Access Monitor™ report, https://www.cegedimstrategicdata.com/ only 54% of prescribers were “rep-accessible”?
  4. 4. Patient Cost’s is also impacting PharmaceuticalPromotion as the rise in co-pay costs is now a barrier Co-pay Amount• First, measures for Tier 4 Specialty Drugs improving adherence must $50 address financial barriers … Tier 3 Other Covered Brand Drugs• Especially the co-payments $40 that patients must make for Tier 2 medications.” Preferred Brand Drugs $25• Patients Are Resisting Tier 1 Increases In Co-pay Costs, Covered Generic Drugs $5 which in turn is affecting Fill Rates/Adherence Source: 3. New England Journal of Medicine https://www.nejm.org/
  5. 5. Key Trends—Trial Vouchers & Coupons Drive Adherence! Co-Pay Cards And Coupons: Letting The Facts Get In The Way Impact Of Co-Pay Offset Program On Patient +20 Days– Adherence to BRAND Increased Loyalty: 270 275 Longer Therapy Than Cohort At +20 DAYS Equivalent Co-Pay 250 250 +40 Days– +40 DAYS 225 Response To Lower 210 Co-pay: More Days Of 200 Therapy Based On Initial Co-Pay Level 175 Sources: 6. Wolters Kluwer Health (PTD search) $25 ECP Co-Pay $25 Co-Pay $50 Co-Pay http://www.wolterskluwerhealth.com/ $60 Co-Pay Control Group 2: Control Group 2: reduced to $25 Paying $25 Paying $60 w/Co-pay Card w/Co-pay Card w/Co-pay Card 7. Pharmaceutical Care Management Association http://www.amundsengroup.com/ Effect Of Moving Patient From $60 to $35 Co-pay
  6. 6. Trial Vouchers & Coupons Are Now Replacing SamplesIndustry report conservatively made the following assumptions: • Nearly all manufacturers offer co- • There were 100M in prescriptions payments not based on income associated with coupons in 2010 or 11% of brand prescriptions • In July 2011 there were 310 co-pay card programs in the US, a 260% increase • Co-pay coupons to increase 15% per from 2009 year from 100M in 2010 to 500M in 2021 • Co-pay cards were 1/3 of overall prescription drug market and 13% of • Co-pay coupons will represent 20% branded drugs of non-specialty brand prescriptions in 2014, 30% in 2017, and 50% in • The $4B Samples Market is going digital 2021 which by way of efficiencies should Improve Adherence Source: 4. Cleveland Resource Company Source: 5. Pharmaceutical Care Management Association http://pcmanet.org/ http://pcmanet.org/
  7. 7. Market Size— Physicians Practice Flow is now Electronic!eprescribing to grow by 600% in five years.? Did You Know… • 570M prescriptions were routed electronically in 2011? • More than 1 in 2 office-based physicians will be e-prescribed in 2011?
  8. 8. SampleMD is partnering with the largest‘ePrescribing’ and electronic healthcare record (EHR)software platforms to reach more targeted careproviders who are active electronic prescribers Allscripts has 70,000 active Physicians ePrescribe users
  9. 9. SampleMD: How it worksSampleMD is a software application that replaces drug samples by allowingdoctors to automatically add sponsored drug trial vouchers & co-pay discountcoupons from their desktops and ePrescribing system.SampleMD resides within our software partners ePrescribe or electronichealth record (EHR) software offerings.SampleMD is already installed in Allscripts Inc. (NASDAQ:MDRX), New Cropand Dr. First, which enables SampleMD to reside in over 300 individual EHRsystems.Doctors are able to offer patients sample vouchers or coupons right withintheir prescribing work flow automation, making it easy and simple to use.Coupon info is automatically sent to pharmacy with eRxSampleMD is paid $4-$5 by the manufacturer each time an ecoupon orevoucher is distributed to a patient.
  10. 10. SampleMD provides Clear Solutions:SampleMD enables branded drug manufacturersaccess to providers with out sales personnel, alongwith access to their patients via a very cost effectiveway to get their cost saving offers directly topatients.SampleMD, by partnering with other softwarepartners, is able to be within the primary workflowof hundred’s of thousands of healthcare providers.SampleMD in turn shares revenue with eachsoftware partner that provides them direct access tohealth care providers.
  11. 11. SampleMD™ Promotional TechnologyEach Platform Offers A Cost-Effective SolutionOptimizeRx website—industry standard,rules-based, and embedded functionality• eCouponing: eVouchers and eCoupons generated from the EMR/ePrescribe System• Patient Education: Access Patient Education and Adherence Programs at the point of prescribing• Product Info & Support: Access product information and live support from the EMR/ePrescribe System• Rep Visit: Health providers can request a Rep Visit and appointment time
  12. 12. SampleMD™ Promotional TechnologyPromotion to Doctors at Most Critical Time: Point of Prescribe! Once product is selected, SampleMD proprietary rules based engine determines eligible product support Doctor searches for drug to ePrescribe Option to send to patient mobile & email Upon doctor sending the ePrescription, your eCoupon & Patient Ed. is auto displayed & printed for patient and coupon info is included right within eRx to pharmacist!
  13. 13. Our Key Health Systems & EHR/ ePrescribe Platform Partners
  14. 14. Key Health Pharmaceutical & Health Care Clients“Building the premier digital path to deliver direct support from leading Pharma Companies”
  15. 15. SampleMD Revenue Metrics: “Highly Leveraged” Set Up Fee: $25K Reporting: $1K/mth. Cost Per Coupon Distribution:NOTE: We do have Enterprise $5.00Wide discounts to promoteManufacturers to add portfolioof products to drive increased volume
  16. 16. SampleMD Actual Usage Metrics July 2011-July2012
  17. 17. OPRX FISCAL PERFORMANCE Q3 2011 v. Q3 2012Fiscal period Revenue for period 9 Mos Q3 loss 9 mos total REVENUE loss2011 Q3 $191,593 $785,610 ($1,087,504) ($2,027,619)2012 Q3 $453,154 $1,297,980 ($106,174)* ($482,969)* The Company broke even on a cash basis prior to non-cash charges in Q3 2012
  18. 18. Thank you for your interest in OPRX Key Stock Data: Equivalents: Financial Summary Recent Price( 12/4/12): 14m warrants are Total assets $2.4m a/o $1.05 outstanding at $2-3 strike 6/30/12 price. 52 Week range: $0.53-$1.97 Management holds certain Liabilities: $1.1 a/o 6/30/12 option agreement’s mostly trade payables MKT CAP: $20.1m primary only Ave Volume: 34,000 Fully diluted share count w (trailing3 mos.) equivalents: 34m.Company: Mr. Dave Harrell, Chairman IR Contact : Mr. Craig Stewart248.651.6568 office 585-737-9966 celldharrell@samplemd.com cstewart@ncainc.com

×